CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition

Malignant pleural mesothelioma is an aggressive cancer, heterogeneous in its presentation and behaviour. Despite an increasing knowledge about molecular markers and their diagnostic and prognostic value, they are not used as much as they might be for treatment allocation. It has been recently report...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Oncol
Hauptverfasser: Pinton, Giulia, Wang, Zhuo, Balzano, Cecilia, Missaglia, Sara, Tavian, Daniela, Boldorini, Renzo, Fennell, Dean A., Griffin, Martin, Moro, Laura
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2021
Schlagworte:
Oncology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8281343/
https://ncbi.nlm.nih.gov/pubmed/34277422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.678447
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge